Summarized Quarterly Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 12 Months Ended | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 27, 2020 |
Jun. 28, 2020 |
Mar. 29, 2020 |
Dec. 29, 2019 |
Sep. 29, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Dec. 30, 2018 |
Sep. 27, 2020 |
Sep. 29, 2019 |
Sep. 30, 2018 |
||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Revenues | $ 8,346 | [1] | $ 4,893 | $ 5,216 | [1] | $ 5,077 | [1] | $ 4,814 | [2] | $ 9,635 | [2] | $ 4,982 | [2] | $ 4,842 | [2] | $ 23,531 | $ 24,273 | $ 22,611 | ||||||
Operating income | 3,452 | [1] | 782 | 991 | [1] | 1,030 | [1] | 701 | [2] | 5,317 | [2] | 940 | [2] | 710 | [2] | 6,255 | 7,667 | 621 | ||||||
Net income | $ 2,960 | [1] | $ 845 | $ 468 | [1] | $ 925 | [1] | $ 506 | [2] | $ 2,149 | [2] | $ 663 | [2] | $ 1,068 | [2] | $ 5,198 | $ 4,386 | $ (4,964) | ||||||
Basic earnings per share | $ 2.62 | [3] | $ 0.75 | $ 0.41 | $ 0.81 | [3] | $ 0.42 | [3] | $ 1.77 | [3] | $ 0.55 | [3] | $ 0.88 | [3] | $ 4.58 | $ 3.63 | $ (3.39) | |||||||
Diluted earnings per share | $ 2.58 | [3] | $ 0.74 | $ 0.41 | $ 0.80 | [3] | $ 0.42 | [3] | $ 1.75 | [3] | $ 0.55 | [3] | $ 0.87 | [3] | $ 4.52 | $ 3.59 | $ (3.39) | |||||||
Other than Temporary Impairment Losses, Investments | $ 265 | $ 405 | $ 135 | $ 75 | ||||||||||||||||||||
Licensing Revenues | 7,233 | 9,662 | 5,211 | |||||||||||||||||||||
Income Tax Expense (Benefit) | 521 | 3,095 | 5,356 | |||||||||||||||||||||
Huawei [Member] | ||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Revenues | $ 1,800 | |||||||||||||||||||||||
Distributed Intellectual Property [Member] | ||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | $ 2,500 | 0 | 2,472 | 0 | ||||||||||||||||||||
U.S. Tax Cuts and Jobs Act Effective 2018 [Member] | ||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Income Tax Expense (Benefit) | $ (570) | 5,700 | ||||||||||||||||||||||
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | $ 0 | $ 0 | $ 443 | |||||||||||||||||||||
Apple [Member] | ||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Licensing Revenues | 4,700 | |||||||||||||||||||||||
Icera Complaint to EC [Member] | ||||||||||||||||||||||||
Loss Contingencies [Line Items] | ||||||||||||||||||||||||
Loss Contingency, Loss in Period | $ 275 | |||||||||||||||||||||||
|
X | ||||||||||
- Definition Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|